BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 22194482)

  • 1. Is there a role for FDG PET in the management of lung cancer manifesting predominantly as ground-glass opacity?
    Kim TJ; Park CM; Goo JM; Lee KW
    AJR Am J Roentgenol; 2012 Jan; 198(1):83-8. PubMed ID: 22194482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ground-glass opacity nodules: histopathology, imaging evaluation, and clinical implications.
    Lee HY; Lee KS
    J Thorac Imaging; 2011 May; 26(2):106-18. PubMed ID: 21508733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of sublobar resection for c-stage IA non-small cell lung cancer based on a combination of structural imaging by CT and functional imaging by FDG PET.
    Yoshioka M; Ichiguchi O
    Ann Thorac Cardiovasc Surg; 2009 Apr; 15(2):82-8. PubMed ID: 19471220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenocarcinoma with BAC features presented as the nonsolid nodule is prone to be false-negative on 18F-FDG PET/CT.
    Wu HB; Wang L; Wang QS; Han YJ; Li HS; Zhou WL; Tian Y
    Biomed Res Int; 2015; 2015():243681. PubMed ID: 25879020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pure ground glass nodular adenocarcinomas: Are preoperative positron emission tomography/computed tomography and brain magnetic resonance imaging useful or necessary?
    Cho H; Lee HY; Kim J; Kim HK; Choi JY; Um SW; Lee KS
    J Thorac Cardiovasc Surg; 2015 Sep; 150(3):514-20. PubMed ID: 26189165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic value of (18)F-FDG PET/CT for solitary nodular-type bronchoalveolar carcinoma].
    Liu W; Li X; Quan J; Ouyang X; Zheng H
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jan; 33(1):114-6. PubMed ID: 23353168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined evaluation of preoperative FDG uptake on PET, ground-glass opacity area on CT, and serum CEA level: identification of both low and high risk of recurrence in patients with resected T1 lung adenocarcinoma.
    Higashi K; Sakuma T; Ito K; Niho S; Ueda Y; Kobayashi T; Sekiguchi R; Takahashi T; Kato T; Tonami H
    Eur J Nucl Med Mol Imaging; 2009 Mar; 36(3):373-81. PubMed ID: 18931837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.
    Yoo IeR; Chung SK; Park HL; Choi WH; Kim YK; Lee KY; Wang YP
    Biomed Mater Eng; 2014; 24(6):3091-103. PubMed ID: 25227018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations among bronchioloalveolar carcinoma components, positron emission tomographic and computed tomographic findings, and malignant behavior in small lung adenocarcinomas.
    Okada M; Tauchi S; Iwanaga K; Mimura T; Kitamura Y; Watanabe H; Adachi S; Sakuma T; Ohbayashi C
    J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1448-54. PubMed ID: 17532938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images.
    Nomori H; Watanabe K; Ohtsuka T; Naruke T; Suemasu K; Uno K
    Lung Cancer; 2004 Jul; 45(1):19-27. PubMed ID: 15196730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solitary ground-glass opacity nodules of stage IA pulmonary adenocarcinoma: combination of 18F-FDG PET/CT and high-resolution computed tomography features to predict invasive adenocarcinoma.
    Zhou J; Li Y; Zhang Y; Liu G; Tan H; Hu Y; Xiao J; Shi H
    Oncotarget; 2017 Apr; 8(14):23312-23321. PubMed ID: 28423576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer.
    Miyasaka Y; Suzuki K; Takamochi K; Matsunaga T; Oh S
    Eur J Cardiothorac Surg; 2013 Jul; 44(1):83-7. PubMed ID: 23233074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical, pathological and thin-section CT features of persistent multiple ground-glass opacity nodules: comparison with solitary ground-glass opacity nodule.
    Kim TJ; Goo JM; Lee KW; Park CM; Lee HJ
    Lung Cancer; 2009 May; 64(2):171-8. PubMed ID: 18799230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localized form of bronchioloalveolar carcinoma: FDG PET findings.
    Kim BT; Kim Y; Lee KS; Yoon SB; Cheon EM; Kwon OJ; Rhee CH; Han J; Shin MH
    AJR Am J Roentgenol; 1998 Apr; 170(4):935-9. PubMed ID: 9530038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent pulmonary nodular ground-glass opacity at thin-section CT: histopathologic comparisons.
    Kim HY; Shim YM; Lee KS; Han J; Yi CA; Kim YK
    Radiology; 2007 Oct; 245(1):267-75. PubMed ID: 17885195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter analysis of high-resolution computed tomography and positron emission tomography/computed tomography findings to choose therapeutic strategies for clinical stage IA lung adenocarcinoma.
    Okada M; Nakayama H; Okumura S; Daisaki H; Adachi S; Yoshimura M; Miyata Y
    J Thorac Cardiovasc Surg; 2011 Jun; 141(6):1384-91. PubMed ID: 21440264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primary tumor SUVmax measured on (18)F-FDG PET-CT correlates with histologic grade and pathologic stage in non-small cell lung cancer].
    Zhao SJ; Wu N; Zheng R; Liu Y; Zhang WJ; Liang Y; Zhang H; Li XM
    Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):754-7. PubMed ID: 24378097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules.
    Bryant AS; Cerfolio RJ
    Ann Thorac Surg; 2006 Sep; 82(3):1016-20. PubMed ID: 16928527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of virtual 18F-FDG PET/CT bronchoscopy for the detection of lymph node metastases in non-small cell lung cancer patients.
    Herbrik M; Treffert J; Geiger B; Riegger C; Hartung V; Rosenbaum-Krumme SJ; Forsting M; Antoch G; Heusner TA
    J Nucl Med; 2011 Oct; 52(10):1520-5. PubMed ID: 21908390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of 18F-2-deoxy-fluoro-D-glucose positron emission tomography for pN1 lymph nodes in patients with lung cancer.
    Nakagawa M; Hara M; Sakurai K; Ozawa Y; Mizuno A; Tamaki T; Nishio M; Shibamoto Y
    Acta Radiol; 2009 Jul; 50(6):638-44. PubMed ID: 19492198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.